Recently stock market analysts have updated their consensus ratings on shares of Anacor Pharmaceuticals, Inc. (ANAC). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

05/03/2016 – Anacor Pharmaceuticals, Inc. had its “outperform” rating reiterated by analysts at Wedbush. They now have a USD 148 price target on the stock.

04/20/2016 – Anacor Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at Jefferies. They now have a USD 105 price target on the stock.

03/22/2016 – Anacor Pharmaceuticals, Inc. had its “outperform” rating reiterated by analysts at Mizuho. They now have a USD 102 price target on the stock.

09/09/2015 – JMP Securities began new coverage on Anacor Pharmaceuticals, Inc. giving the company a “market outperform” rating. They now have a USD 173 price target on the stock.

07/21/2015 – Anacor Pharmaceuticals, Inc. was upgraded to “buy” by analysts at Bank of America Merrill Lynch.

07/21/2015 – Anacor Pharmaceuticals, Inc. was upgraded to “buy” by analysts at Goldman Sachs. They now have a USD 195 price target on the stock.

09/09/2014 – Avondale Partners began new coverage on Anacor Pharmaceuticals, Inc. giving the company a “outperform” rating.

07/08/2014 – Anacor Pharmaceuticals, Inc. was upgraded to “neutral” by analysts at Zacks. They now have a USD 17.2 price target on the stock.

05/09/2014 – Anacor Pharmaceuticals, Inc. was downgraded to “hold” by analysts at TheStreet.

03/14/2014 – Anacor Pharmaceuticals, Inc. was upgraded to “hold” by analysts at EVA Dimensions.

10/29/2013 – Anacor Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at Canaccord Genuity. They now have a USD 24 price target on the stock.

10/18/2013 – Anacor Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at Deutsche Bank. They now have a USD 20 price target on the stock.

Anacor Pharmaceuticals, Inc. has a 50 day moving average of 62.60 and a 200 day moving average of 85.01. The stock’s market capitalization is 2.59B, it has a 52-week low of 52.00 and a 52-week high of 156.93.

The share price of the company (ANAC) was up +0.19%, with a high of 60.36during the day and the volume of Anacor Pharmaceuticals, Inc. shares traded was 1460679.

View other investors thoughts on Anacor Pharmaceuticals, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.